Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Criswell

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1996
Eosinophilia-myalgia syndrome. Status of patients at onset and after four years of diseaseL A Criswell, T Pincus
Rheumatology (Oxford, England)|November 25, 2005
Current understanding of the genetic aetiology of rheumatoid arthritis and likely future developmentsL A Criswell, P K Gregersen
The Western Journal of Medicine|September 1, 1990
Tryptophan-induced eosinophilia-myalgia syndromeL A Criswell, K E Sack
Current Opinion in Rheumatology|April 6, 2000
Update on genetic risk factors for systemic lupus erythematosus and rheumatoid arthritisL A Criswell, C I Amos
The Western Journal of Medicine|February 1, 1991
Drs criswell and sack respondL A Criswell, K E Sack
The Journal of Rheumatology|May 1, 1995
What explains the variation among rheumatologists in their use of prednisone and second line agents for the treatment of rheumatoid arthritis?L A Criswell, C J Henke
The Journal of Rheumatology. Supplement|March 1, 1996
Cost effectiveness analysis of drug therapies for rheumatoid arthritisL A Criswell, C L Such
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|December 1, 1996
Differences in symptom reports between men and women with rheumatoid arthritisP P Katz, L A Criswell
Southern Medical Journal|September 1, 1992
Eosinophilia-myalgia syndrome: the aftermathK E Sack, L A Criswell
Arthritis and Rheumatism|November 1, 1992
Auranofin, methotrexate, but no placebo: comment on the article by Williams et alW V Epstein, L A Criswell
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Advances in Experimental Medicine and Biology|January 1, 1996
Eosinophilia-myalgia syndrome. Status of patients at onset and after four years of diseaseL A Criswell, T Pincus
Rheumatology (Oxford, England)|November 25, 2005
Current understanding of the genetic aetiology of rheumatoid arthritis and likely future developmentsL A Criswell, P K Gregersen
The Western Journal of Medicine|September 1, 1990
Tryptophan-induced eosinophilia-myalgia syndromeL A Criswell, K E Sack
Current Opinion in Rheumatology|April 6, 2000
Update on genetic risk factors for systemic lupus erythematosus and rheumatoid arthritisL A Criswell, C I Amos
The Western Journal of Medicine|February 1, 1991
Drs criswell and sack respondL A Criswell, K E Sack
The Journal of Rheumatology|May 1, 1995
What explains the variation among rheumatologists in their use of prednisone and second line agents for the treatment of rheumatoid arthritis?L A Criswell, C J Henke
The Journal of Rheumatology. Supplement|March 1, 1996
Cost effectiveness analysis of drug therapies for rheumatoid arthritisL A Criswell, C L Such
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|December 1, 1996
Differences in symptom reports between men and women with rheumatoid arthritisP P Katz, L A Criswell
Southern Medical Journal|September 1, 1992
Eosinophilia-myalgia syndrome: the aftermathK E Sack, L A Criswell
Arthritis and Rheumatism|November 1, 1992
Auranofin, methotrexate, but no placebo: comment on the article by Williams et alW V Epstein, L A Criswell
Pageof 7